Literature DB >> 19998159

Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results.

John D Banja1, Boadie Dunlop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19998159      PMCID： PMC3717209          DOI： 10.1080/15265160902948330

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  9 in total

Review 1.  Why should we include women and minorities in randomized controlled trials?

Authors:  C Weijer; R A Crouch
Journal:  J Clin Ethics       Date:  1999

2.  What makes placebo-controlled trials unethical?

Authors:  Franklin G Miller; Howard Brody
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

Review 3.  Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research.

Authors:  B Freedman; A Fuks; C Weijer
Journal:  Clin Res       Date:  1992-12

4.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 5.  Conflicts of interest in pain medicine: Practice patterns and relationships with industry.

Authors:  Jerome Schofferman; John Banja
Journal:  Pain       Date:  2008-09-24       Impact factor: 6.961

6.  The duty to disclose adverse clinical trial results.

Authors:  S Matthew Liao; Mark Sheehan; Steve Clarke
Journal:  Am J Bioeth       Date:  2009-08       Impact factor: 11.229

7.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

8.  A plea for pragmatism in clinical research ethics.

Authors:  David H Brendel; Franklin G Miller
Journal:  Am J Bioeth       Date:  2008-04       Impact factor: 11.229

9.  A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders.

Authors:  B W Dunlop; J Banja
Journal:  J Med Ethics       Date:  2009-06       Impact factor: 2.903
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.